©The Author(s) 2025.
World J Diabetes. Nov 15, 2025; 16(11): 112999
Published online Nov 15, 2025. doi: 10.4239/wjd.v16.i11.112999
Published online Nov 15, 2025. doi: 10.4239/wjd.v16.i11.112999
Table 1 Patterns of switching between different glucagon-like peptide-1 receptor agonists, n (%)
| Total (70645) | Switched [18047 (25.5)] | Exenatide BID | Liraglutide | Lixisenatide | Exenatide ER | Dulaglutide | Semaglutide | |
| Daily GLP-1RA | 30699 | 10144 (33) | ||||||
| Exenatide BID | 1624 | 775 (47.7) | - | 673 | 13 | 71 | 18 | 0 |
| Liraglutide | 27596 | 8905 (32.2) | 199 | - | 553 | 1148 | 4044 | 2961 |
| Lixisenatide | 1479 | 464 (31.4) | 0 | 161 | - | 85 | 201 | 17 |
| Weekly GLP-1RA | 39955 | 7903 (19.8) | ||||||
| Exenatide ER | 4896 | 1755 (35.8) | - | 338 | 69 | - | 1187 | 161 |
| Dulaglutide | 30062 | 5783 (19.2) | 0 | 584 | 13 | 113 | - | 5073 |
| Semaglutide | 4997 | 365 (7.3) | 0 | 18 | 0 | 0 | 347 | - |
- Citation: Kassem S, Khalaila B, Stein N, Zaina A. Glucagon-like peptide 1 receptor agonists switching patterns in type two diabetes: A retrospective real-world study. World J Diabetes 2025; 16(11): 112999
- URL: https://www.wjgnet.com/1948-9358/full/v16/i11/112999.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i11.112999